DE3786456T2 - Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen. - Google Patents

Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen.

Info

Publication number
DE3786456T2
DE3786456T2 DE87907079T DE3786456T DE3786456T2 DE 3786456 T2 DE3786456 T2 DE 3786456T2 DE 87907079 T DE87907079 T DE 87907079T DE 3786456 T DE3786456 T DE 3786456T DE 3786456 T2 DE3786456 T2 DE 3786456T2
Authority
DE
Germany
Prior art keywords
vicious
combinations
treatment
inflammatory agents
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87907079T
Other languages
English (en)
Other versions
DE3786456D1 (de
Inventor
Alfred Goldberg
Walter Fiers
Isis Kettelhut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Biogen Inc
Original Assignee
Harvard College
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Biogen Inc filed Critical Harvard College
Application granted granted Critical
Publication of DE3786456D1 publication Critical patent/DE3786456D1/de
Publication of DE3786456T2 publication Critical patent/DE3786456T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE87907079T 1986-10-16 1987-10-14 Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen. Expired - Fee Related DE3786456T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91985186A 1986-10-16 1986-10-16

Publications (2)

Publication Number Publication Date
DE3786456D1 DE3786456D1 (de) 1993-08-12
DE3786456T2 true DE3786456T2 (de) 1994-02-03

Family

ID=25442745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87907079T Expired - Fee Related DE3786456T2 (de) 1986-10-16 1987-10-14 Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen.

Country Status (7)

Country Link
EP (1) EP0287633B1 (de)
JP (1) JPH01500905A (de)
AT (1) ATE91237T1 (de)
DE (1) DE3786456T2 (de)
IL (1) IL84189A0 (de)
WO (1) WO1988002632A1 (de)
ZA (1) ZA877771B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508031A (en) * 1986-11-21 1996-04-16 Cetus Oncology Corporation Method for treating biological damage using a free-radial scavenger and interleukin-2
DE3816169A1 (de) * 1988-05-11 1989-11-23 Boehringer Ingelheim Kg Verwendung und mittel zur verminderung der nebenwirkungen von tnf
US6042837A (en) * 1989-09-20 2000-03-28 Kalland; Terje Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)
US5728388A (en) * 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
DE69133068T2 (de) * 1990-01-17 2003-03-13 David S Terman Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
EP0584220A1 (de) * 1991-05-14 1994-03-02 Endocon, Inc. Anlegen der lokalen entzündungsreaktion als ein mittel zur kontrollierten wirkstoffreisetzung
US6255347B1 (en) 1996-06-21 2001-07-03 Advanced Research And Technology Institute Methods and compositions comprising R-ibuprofen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
WO1987006830A1 (en) * 1986-05-09 1987-11-19 Sloan-Kettering Institute For Cancer Research Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment

Also Published As

Publication number Publication date
JPH01500905A (ja) 1989-03-30
IL84189A0 (en) 1988-03-31
EP0287633A4 (de) 1989-02-23
ATE91237T1 (de) 1993-07-15
WO1988002632A1 (en) 1988-04-21
ZA877771B (en) 1988-09-28
EP0287633A1 (de) 1988-10-26
DE3786456D1 (de) 1993-08-12
EP0287633B1 (de) 1993-07-07

Similar Documents

Publication Publication Date Title
DE69621012T2 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
DE69202441D1 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
DE3786456T2 (de) Kombinationen von nekrose-tumor-faktoren und entzündungshemmenden mitteln für die behandlung von bösartigen und nicht bösartigen erkrankungen.
DK47089D0 (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
NO931413L (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
ATE149840T1 (de) Behandlung von leberkrebs
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
DK374584D0 (da) Analgetikum
NO930305D0 (no) Anvendelse av canp-inhibitorer i farmasoeytiske preparater
ATE65027T1 (de) Behandlung von parasiterkrankungen.
CA2197139A1 (en) A drug for the treatment of cancer
DK0455769T3 (da) Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker
FR2355499A1 (fr) Nouveau derive de l'isoindoline, sa preparation et les compositions qui le contiennent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee